Pricing Log in Create free account
Friday 6 November 2026 Export ADMA’s income statement to Excel — free account

ADMA Biologics Inc

ADMA Healthcare Biotechnology

ADMA Biologics Inc’s revenue for fiscal 2025 (year ended December 2025) was $510.2 million, up 19.6% from fiscal 2024.

Revenue
+5.12%
EPS
+46.7%
Free cash flow
+1,709.5%
Total debt
+140.5%

Quarter to September 2026, against a year earlier

12.78 0.43 −3.26%
Market cap
$3.0B
P/E
16.7×
Fwd P/E
14.0×
Dividend yield
—
F-score
5/9
Altman Z
19.98
Beneish M
−0.17
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

ADMA Biologics Inc (ADMA) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, ADMA Biologics Inc (ADMA) trades at a EV/Sales of 5.8×. Over the past ten years it has ranged from 2.8× (January 2022) to 17.2× (April 2019); the current reading is higher than 44% of that period. That is below the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 8.5× (8.84%)
FY2024 9.3× 117.18%
FY2023 4.3× (20.61%)
FY2022 5.4× 76.26%
FY2021 3.1× (38.21%)
FY2020 5.0× (47.09%)
FY2019 9.4× 25.77%
FY2018 7.5× 133.63%
FY2017 3.2× (40.85%)
FY2016 5.4× (52.46%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.5× 15.92%
Jun 2026 3.9× (10.27%)
Mar 2026 4.3× (49.47%)
Dec 2025 8.5× 18.07%
43 more quarters

Against its own ten years

Low 2.8× High 17.2×
Ten-year median 6.6×
Current reading's percentile 48

EV/Sales against peers

Company EV/Sales
PHVS Pharvaris N.V. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
BHVN Biohaven Ltd. compare 2.2×
AUPH Aurinia Pharmaceuticals Inc compare 5.3×
ADMA ADMA Biologics Inc 5.8×
VCEL Vericel Corporation compare 7.6×
PVLA Palvella Therapeutics, Inc. compare 48.1×
IMNM Immunome, Inc. compare 121×
CLDX Celldex Therapeutics, Inc. compare 1,691×
Biotechnology industry median 9.0×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ADMA